Ohio State is in the process of revising websites and program materials to accurately reflect compliance with the law. While this work occurs, language referencing protected class status or other activities prohibited by Ohio Senate Bill 1 may still appear in some places. However, all programs and activities are being administered in compliance with federal and state law.

Technology developed in Dehua Pei's lab leads to outstanding commercialization deal

December 18, 2018

Technology developed in Dehua Pei's lab leads to outstanding commercialization deal

Dr. Dehua Pei

Please join the department in congratulating Dehua on the success of his efforts to commercialize key cyclic peptides for intracellular delivery of proteins.   Chris Paschall of TCO states, “We believe it’s the largest deal in the history of Ohio State in terms of the upfront fee ($400K), and largest ever Series A financing round by an Ohio State spinout ($59M).  The value of the deal speaks to the tremendous work that Dehua has done over the years.”

Fierce Biotech Article

Xconomy Article

PR Newswire Article

Ohio State News

We greatly appreciate Dehua’s leadership in commercialization.   His success is heartwarming and encouraging to others in the department who are moving technologies toward commercialization.

Dehua, we hope your innovations will help millions!